Evaluation of the value of diabetes risk scores in screening for undiagnosed diabetes and prediabetes: a community-based study in southwestern China

References

• Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020;369:m997.
   PubMedGoogle Scholar
• International Diabetes Federation. IDF diabetes atlas. 9th. Brussels, Belgium: International Diabetes Federation; 2019. Available from: http://www.diabetesatlas.org
   Google Scholar
• Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;317:2515–2523.
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310:948–958.
   PubMed Web of Science ®Google Scholar
• Lindstrom J, Tuomilehto J. The diabetes risk score: A practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26:725–731.
   PubMed Web of Science ®Google Scholar
• Bang H, Edwards AM, Bomback AS, et al. A patient self-assessment diabetes screening score. Ann Intern Med. 2009;151:775–783.
   PubMed Web of Science ®Google Scholar
• Gray LJ, Taub NA, Khunti K, et al. The leicester risk assessment score for detecting undiagnosed type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med. 2010;27:887–895.
   PubMed Web of Science ®Google Scholar
• Zhou X, Qiao Q, Ji L, et al. Nonlaboratory-based risk assessment algorithm for undiagnosed type 2 diabetes developed on a nation-wide diabetes survey. Diabetes Care. 2013;36:3944–3952.
   PubMed Web of Science ®Google Scholar
• Gao WG, Dong YH, Pang ZC, et al. A simple Chinese risk score for undiagnosed diabetes. Diabet Med. 2010;27:274–281.
   PubMed Web of Science ®Google Scholar
• Glümer C, Carstensen B, Sandbaek A, et al. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care. 2004;27:727–733.
   PubMed Web of Science ®Google Scholar
• Wang K, Li T, Xiang H. Study on the epidemiological characteristics of diabetes mellitus and IGT in China. Chin J Epidemiol. 1998;19:282–285.
   Google Scholar
• Ze Y. A survey of diabetes prevalence in the middle-aged and elderly Chinese from 12 areas of China. Chin J Endocrinol Metab. 2002;18:280–284.
   Google Scholar
• World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications : report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus. 1999;
   Google Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2020. Diabetes Care. 2020;43:S14–S31.
   PubMed Web of Science ®Google Scholar
• Moons KGM, de Groot JAH, Bouwmeester W, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med. 2014;11:e1001744.
   PubMed Web of Science ®Google Scholar
• Zhou H, Li Y, Liu X, et al. Development and evaluation of a risk score for type 2 diabetes mellitus among middle-aged Chinese rural population based on the RuralDiab Study. Sci Rep. 2017;7:42685.
   PubMed Web of Science ®Google Scholar
• Wu J, Hou X, Chen L, et al. Development and validation of a non-invasive assessment tool for screening prevalent undiagnosed diabetes in middle-aged and elderly Chinese. Prev Med. 2019;119:145–152.
   PubMed Web of Science ®Google Scholar
• Woo YC, Gao B, Lee CH, et al. Three‐component non‐invasive risk score for undiagnosed diabetes in Chinese people: development, validation and longitudinal evaluation. J Diabetes Investig. 2020;11:341–348.
   PubMed Web of Science ®Google Scholar
• Mohan V, Deepa R, Deepa M, et al. A simplified indian diabetes risk score for screening for undiagnosed diabetic subjects. J Assoc Physicians India. 2005;53:5.
   Google Scholar
• Robinson CA, Agarwal G, Nerenberg K. Validating the CANRISK prognostic model for assessing diabetes risk in Canada’s multi-ethnic population. Chronic Dis Inj Can. 2011;32:19–31.
   PubMedGoogle Scholar
• Zhang Y, Sun J, Pang Z, et al. Evaluation of two screening methods for undiagnosed diabetes in China: an cost-effectiveness study. Prim Care Diab. 2013;7:275–282.
   PubMed Web of Science ®Google Scholar
• National Bureau of Statistics of China. China Statistical Yearbook 2017 version. Available from: http://www.stats.gov.cn/tjsj/ndsj/2017/indexch.htm. Accessed September 11, 2020.
   Google Scholar
• Ministry of Health of the People’s Republic of China, National Development and Reform Commission, and State Administration of Traditional Chinese Medicine of the People’s Republic of China. Norms of national medical service items pricing of China 2012 version.
   Google Scholar
• Moons KGM, Wolff RF, Riley RD, et al. PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med. 2019;170:W1–W33.
   PubMed Web of Science ®Google Scholar
• Park P, Simmons RK, Prevost AT, et al. Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice. BMC Public Health. 2008;8:350.
   PubMed Web of Science ®Google Scholar
• Eborall HC, Griffin SJ, Prevost AT, et al. Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ. 2007;335:486.
   PubMedGoogle Scholar
• Adriaanse MC, Snoek FJ, Dekker JM, et al. No substantial psychological impact of the diagnosis of Type 2 diabetes following targeted population screening: the hoorn screening study. Diabet Med. 2004;21:992–998.
   PubMed Web of Science ®Google Scholar
• Edelman D, Olsen MK, Dudley TK, et al. Impact of diabetes screening on quality of life. Diabetes Care. 2002;25:1022–1026.
   PubMed Web of Science ®Google Scholar
• Chatterjee R, Narayan KMV, Lipscomb J, et al. Screening adults for pre-diabetes and diabetes may be cost-saving. Diabetes Care. 2010;33:1484–1490.
   PubMed Web of Science ®Google Scholar
• Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing diabetes prevention study: a 20-year follow-up study. Lancet. 2008;371:1783–1789.
   PubMed Web of Science ®Google Scholar
• Gong Q, Zhang P, Wang J, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the da qing diabetes prevention outcome study. Lancet Diabetes Endocrinol. 2019;7:452–461.
   PubMed Web of Science ®Google Scholar
• Diabetes Prevention Program Research Group. Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the diabetes prevention program and diabetes prevention program outcomes study. Diabetes Care. 2019;42:601–608.
   PubMed Web of Science ®Google Scholar
• Nathan DM, Barrett-Connor E, Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the diabetes prevention program outcomes study. Lancet Diabetes Endocrinol. 2015;3:866–875.
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Peltonen M, Eriksson JG, et al. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised finnish diabetes prevention study (DPS). Diabetologia. 2013;56:284–293.
   PubMed Web of Science ®Google Scholar
• Holman RR, Coleman RL, Chan JCN, et al. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2017;5:877–886.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tripathy D, Schwenke DC, et al. Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med. 2011;364:1104–1115.
   PubMed Web of Science ®Google Scholar
• Armato JP, DeFronzo RA, Abdul-Ghani M, et al. Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES). Lancet Diabetes Endocrinol. 2018;6:781–789.
   PubMed Web of Science ®Google Scholar
• Jia W, Zhang P, Duolikun N, et al. Study protocol for the road to hierarchical diabetes management at primary care (ROADMAP) study in China: a cluster randomised controlled trial. BMJ Open. 2020;10:e032734.
   PubMed Web of Science ®Google Scholar
• Jia W, Tong N. Diabetes prevention and continuing health-care reform in China. Lancet Diabetes Endocrinol. 2015;3:840–842.
   PubMed Web of Science ®Google Scholar
• Wenying Y, Juming L, Jianping W, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090–1101.
   PubMedGoogle Scholar
• Hu D, Fu P, Xie J, et al. Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: the InterASIA study. Diabetes Res Clin Pract. 2008;81:250–257.
   PubMed Web of Science ®Google Scholar